A Jonason ET AL: "Development of an anti-SEMA4D monoclonal antibody for the treatment of Multiple Sclerosis", , 1 January 2012 (2012-01-01), XP055367292, Retrieved from the Internet: URL:http://vaccinex.com/wp/wp-content/uplo ads/2015/02/ectrims1.pdf [retrieved on 2017-04-25] (B1)

WO-A1-2013/055922 (B1)

EP-A1- 1 442 749 (B1)

FISHER T ET AL: "Development of an anti-SEMA4D monoclonal antibody for the treatment of Multiple Sclerosis", 5TH JOINT TRIENNIAL CONGRESS OF THE EUROPEAN AND AMERICAS COMMITTEES FOR TREATMENT AND RESEARCH IN MULTIPLE SCLEROSIS 19 - 22 OCTOBER 2011, AMSTERDAM, THE NETHERLANDS, , 19 October 2011 (2011-10-19), XP002743917, Retrieved from the Internet: URL:http://registration.akm.ch/einsicht.ph p?XNABSTRACT_ID=138346&XNSPRACHE_ID=2&XNKO NGRESS_ID=150&XNMASKEN_ID=900 (B1)

LYKETSOS ET AL.: 'Neuropsychiatric symptoms in Alzheimer's disease.' ALZHEIMERS DEMENT. vol. 7, no. 5, 2011, pages 532 - 9, XP055334777 (B1)

MASTERMAN D: "Treatment of the Neuropsychiatric Symptoms in Alzheimer's Disease", JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, ELSEVIER, NL, vol. 4, no. 6, 1 November 2003 (2003-11-01), pages S146-S154, XP004793713, ISSN: 1525-8610, DOI: 10.1016/S1525-8610(04)70406-5 (B1)

NUBER ET AL.: 'Neurodegeneration and Motor Dysfunction in a Conditional Model of Parkinson's Disease.' J NEUROSCI. vol. 28, no. 10, 2008, pages 2471 - 84, XP055334781 (B1)

PALMER A M: "The role of the blood brain barrier in neurodegenerative disorders and their treatment", JOURNAL OF ALZHEIMER'S DIS, IOS PRESS, NL, vol. 24, no. 4, 1 January 2011 (2011-01-01), pages 643-656, XP009194362, ISSN: 1387-2877 (B1)

SMITH ET AL.: 'SEMA4D compromises blood-brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease.' NEUROBIOL DIS vol. 73, January 2015, pages 254 - 268, XP055169178 (B1)

SOUTHWELL AMBER L ET AL: "Anti-semaphorin 4D immunotherapy ameliorates neuropathology and some cognitive impairment in the YAC128 mouse model of Huntington disease", NEUROBIOLOGY OF DISEASE, vol. 76, 3 February 2015 (2015-02-03), pages 46-56, XP029147739, ISSN: 0969-9961, DOI: 10.1016/J.NBD.2015.01.002 (B1)

SRIKANTH ET AL: "Neuropsychiatric symptoms in dementia-frequency, relationship to dementia severity and comparison in Alzheimer's disease, vascular dementia and frontotemporal dementia", JOURNAL OF NEUROLOGICAL SCIENCES, ELSEVIER SCIENTIFIC PUBLISHING CO, AMSTERDAM, NL, vol. 236, no. 1-2, 15 September 2005 (2005-09-15), pages 43-48, XP005044526, ISSN: 0022-510X (B1)

T. OKUNO ET AL: "Roles of Sema4D-Plexin-B1 Interactions in the Central Nervous System for Pathogenesis of Experimental Autoimmune Encephalomyelitis", THE JOURNAL OF IMMUNOLOGY, vol. 184, no. 3, 28 December 2009 (2009-12-28), pages 1499-1506, XP055149724, ISSN: 0022-1767, DOI: 10.4049/jimmunol.0903302 (B1)

TATSUSADA OKUNO ET AL: "The role of immune semaphorins in multiple sclerosis", FEBS LETTERS, ELSEVIER, AMSTERDAM, NL, vol. 585, no. 23, 16 March 2011 (2011-03-16), pages 3829-3835, XP028118474, ISSN: 0014-5793, DOI: 10.1016/J.FEBSLET.2011.03.033 [retrieved on 2011-03-19] (B1)

US-A1- 2013 095 118 (B1)

Anonymous: "NCT01764737: Evaluation of Safety, Tolerability and PK of VX15/2503 in Patients with MS", , 2 August 2013 (2013-08-02), XP055367325, Retrieved from the Internet: URL:https://clinicaltrials.gov/archive/NCT 01764737/2013_08_02 [retrieved on 2017-04-25] (B1)